Loss of heterozygosity on the short arm of chromosome 8 in male breast carcinomas. 1995

R F Chuaqui, and J Sanz-Ortega, and C Vocke, and W M Linehan, and J Sanz-Esponera, and Z Zhuang, and M R Emmert-Buck, and M J Merino
Laboratory of Pathology, National Cancer Institute, Bethesda, Maryland 20892, USA.

Identification of loss of heterozygosity (LOH) at specific genetic loci in neoplastic cells suggests the presence of a tumor suppressor gene within the deleted region. LOH on chromosome 8p has been identified in colorectal, bladder, hepatocellular, and prostatic carcinomas. Little is currently known about the molecular events occurring during the development of male breast cancer. We studied LOH on chromosome 8p in 23 male breast carcinomas. Five polymorphic DNA markers were used: D8S136 and D8S137 on 8p12-21.3; and D8S254, D8S258, and D8S349 on 8p22. DNA was extracted from microdissected normal and tumor cells obtained from formalin-fixed, paraffin-embedded tissue sections and amplified by the PCR. LOH was identified in 19 of 23 cases (83%) with at least one marker. Seven cases showed LOH only at 8p22, six cases showed LOH only at 8p12-21.3, and six cases showed LOH at both 8p22 and 8p12-21.3. In five of these last six cases, at least one locus was retained between the two deleted regions; thus, the whole short arm of chromosome 8 was not lost in these tumors. Our results show that there are two discrete areas of deletion on chromosome 8p in male breast cancer, suggesting the presence of one or more tumor suppressor genes that may play a role in the development or progression of the disease.

UI MeSH Term Description Entries
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D002898 Chromosomes, Human, Pair 8 A specific pair of GROUP C CHROMOSOMES of the human chromosome classification. Chromosome 8
D004273 DNA, Neoplasm DNA present in neoplastic tissue. Neoplasm DNA
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006579 Heterozygote An individual having different alleles at one or more loci regarding a specific character. Carriers, Genetic,Genetic Carriers,Carrier, Genetic,Genetic Carrier,Heterozygotes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D017353 Gene Deletion A genetic rearrangement through loss of segments of DNA or RNA, bringing sequences which are normally separated into close proximity. This deletion may be detected using cytogenetic techniques and can also be inferred from the phenotype, indicating a deletion at one specific locus. Deletion, Gene,Deletions, Gene,Gene Deletions
D018567 Breast Neoplasms, Male Any neoplasms of the male breast. These occur infrequently in males in developed countries, the incidence being about 1% of that in females. Male Breast Neoplasms,Neoplasms, Breast, Male,Breast Cancer, Male,Breast Carcinoma, Male,Breast Tumors, Male,Male Breast Cancer,Neoplasms, Male Breast,Tumors, Breast, Male,Breast Neoplasm, Male,Breast Tumor, Male,Cancer, Male Breast,Carcinoma, Male Breast,Male Breast Carcinoma,Male Breast Neoplasm,Male Breast Tumor,Male Breast Tumors,Neoplasm, Male Breast,Tumor, Male Breast,Tumors, Male Breast

Related Publications

R F Chuaqui, and J Sanz-Ortega, and C Vocke, and W M Linehan, and J Sanz-Esponera, and Z Zhuang, and M R Emmert-Buck, and M J Merino
January 1995, Cancer genetics and cytogenetics,
R F Chuaqui, and J Sanz-Ortega, and C Vocke, and W M Linehan, and J Sanz-Esponera, and Z Zhuang, and M R Emmert-Buck, and M J Merino
July 1995, Genes, chromosomes & cancer,
R F Chuaqui, and J Sanz-Ortega, and C Vocke, and W M Linehan, and J Sanz-Esponera, and Z Zhuang, and M R Emmert-Buck, and M J Merino
July 1996, Genes, chromosomes & cancer,
R F Chuaqui, and J Sanz-Ortega, and C Vocke, and W M Linehan, and J Sanz-Esponera, and Z Zhuang, and M R Emmert-Buck, and M J Merino
April 1995, Japanese journal of cancer research : Gann,
R F Chuaqui, and J Sanz-Ortega, and C Vocke, and W M Linehan, and J Sanz-Esponera, and Z Zhuang, and M R Emmert-Buck, and M J Merino
January 1998, International journal of cancer,
R F Chuaqui, and J Sanz-Ortega, and C Vocke, and W M Linehan, and J Sanz-Esponera, and Z Zhuang, and M R Emmert-Buck, and M J Merino
July 1997, Genes, chromosomes & cancer,
R F Chuaqui, and J Sanz-Ortega, and C Vocke, and W M Linehan, and J Sanz-Esponera, and Z Zhuang, and M R Emmert-Buck, and M J Merino
September 1998, Oncogene,
R F Chuaqui, and J Sanz-Ortega, and C Vocke, and W M Linehan, and J Sanz-Esponera, and Z Zhuang, and M R Emmert-Buck, and M J Merino
July 1991, Cancer genetics and cytogenetics,
R F Chuaqui, and J Sanz-Ortega, and C Vocke, and W M Linehan, and J Sanz-Esponera, and Z Zhuang, and M R Emmert-Buck, and M J Merino
March 1992, Neurological research,
R F Chuaqui, and J Sanz-Ortega, and C Vocke, and W M Linehan, and J Sanz-Esponera, and Z Zhuang, and M R Emmert-Buck, and M J Merino
August 2000, Oncology,
Copied contents to your clipboard!